Why Eli Lilly and Company (LLY) is the Best Long-Term Growth Stock to Buy Now
We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...
Irish Examiner12h
Innovating beyond boundaries: Sarah O’Keeffe’s career in making medicine
Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...
A Promising Development for Millions of People With Liver Disease
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
clinicaltrialsarena4h
OCT West Coast 2025: China surpasses US for annual number of clinical trials
GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
Pharmaceutical Technology3h
Abcuro secures $200m as it eyes approval for rare muscle disease drug
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Le Lézard5h
DIA 2025 Global Annual Meeting Highlights Need for Neutral Collaborations to Advance Innovations in Biomedical Science and Healthcare
DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all over the world to address opportunities for collaboration in medical ...
PharmiWeb5h
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents
We recently compiled a list of the Top 10 Must-See AI News Updates for Investors. In this article, we are going to take a ...